AKR1B10 and neoplasm: Using bioinformatics analysis, real-time quantitative polymerase chain reaction (qPCR), and co-immunoprecipitation, assays, Yao et al. [108] convincingly demonstrated that AKR1B10 functions as a tumor suppressor in gastric cancer by inhibiting integrin subunit alpha 5.